Diabetes

Late-life diabetes status tied to new cognitive impairment

(HealthDay)—Having diabetes, poor glycemic control, and longer diabetes duration are associated with worse cognitive outcomes in older adults during a median follow-up of five years, according to a study recently published ...

Cardiology

No evidence of legacy effect seen for intensive glucose lowering

(HealthDay)—There seems to be no evidence of a legacy effect or mortality benefit for intensive glucose control among military veterans with type 2 diabetes, according to a study published in the June 6 issue of the New ...

Medical research

New genetic weapons challenge sickle cell disease

Help for patients with sickle cell disease may soon come from gene editing to fix the mutation that causes the disease and boost the patient's own protective fetal hemoglobin.

Diabetes

Exercise, therapy may improve depression, diabetes outcomes

(HealthDay)—Exercise and/or behavioral treatment interventions may provide clinically meaningful improvements in depression outcomes in adults with type 2 diabetes (T2DM) and major depressive disorder (MDD), according to ...

Diabetes

Poor glycemic control linked to sarcopenia in T2DM

(HealthDay)—For patients with type 2 diabetes, poor glycemic control is associated with sarcopenia, according to a study published online May 9 in the Journal of Diabetes Investigation.

Medications

Medication nonadherence common in patients with T2DM

(HealthDay)—Routine urine samples can be used to test for medication adherence in patients with type 2 diabetes, according to a study published in the June issue of Diabetes Care.

Diabetes

Dapagliflozin improves glucose outcomes in type 1 diabetes

(HealthDay)—In patients with type 1 diabetes, treatment with dapagliflozin for 24 weeks improves time in range, mean glucose, and glycemic variability, according to a study published online April 9 in Diabetes Care.

page 2 from 23